153 related articles for article (PubMed ID: 36670456)
1. Ovarian seromucinous carcinoma: an independent epithelial ovarian cancer?
Hu Y; Fu K; Liu H; He Q; Qiu X; Yang W; Zhang Y
J Ovarian Res; 2023 Jan; 16(1):18. PubMed ID: 36670456
[TBL] [Abstract][Full Text] [Related]
2. Ovarian seromucinous tumors: clinicopathological features of 10 cases with a detailed review of the literature.
Idrees R; Din NU; Siddique S; Fatima S; Abdul-Ghafar J; Ahmad Z
J Ovarian Res; 2021 Mar; 14(1):47. PubMed ID: 33736662
[TBL] [Abstract][Full Text] [Related]
3. Ovarian seromucinous carcinoma: report of a series of a newly categorized and uncommon neoplasm.
Taylor J; McCluggage WG
Am J Surg Pathol; 2015 Jul; 39(7):983-92. PubMed ID: 25723110
[TBL] [Abstract][Full Text] [Related]
4. [Clinicopathologic study of seromucinous carcinoma of ovary].
Tang SX; Sun YH; Xu Y; Zhou XR; Yang WT
Zhonghua Bing Li Xue Za Zhi; 2016 Nov; 45(11):774-779. PubMed ID: 27821232
[No Abstract] [Full Text] [Related]
5. Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary.
Rambau PF; McIntyre JB; Taylor J; Lee S; Ogilvie T; Sienko A; Morris D; Duggan MA; McCluggage WG; Köbel M
Am J Surg Pathol; 2017 May; 41(5):685-695. PubMed ID: 28125452
[TBL] [Abstract][Full Text] [Related]
6. Seromucinous ovarian tumor A comparison with the rest of ovarian epithelial tumors.
Karpathiou G; Chauleur C; Corsini T; Venet M; Habougit C; Honeyman F; Forest F; Peoc'h M
Ann Diagn Pathol; 2017 Apr; 27():28-33. PubMed ID: 28325358
[TBL] [Abstract][Full Text] [Related]
7. Seromucinous component in endometrioid endometrial carcinoma as a histological predictor of prognosis.
Miyamoto M; Takano M; Aoyama T; Soyama H; Yoshikawa T; Tsuda H; Furuya K
J Gynecol Oncol; 2018 Mar; 29(2):e20. PubMed ID: 29400013
[TBL] [Abstract][Full Text] [Related]
8. Anaplastic carcinoma in ovarian seromucinous cystic tumor of borderline malignancy.
Okumura T; Muronosono E; Tsubuku M; Terao Y; Takeda S; Maruyama M
J Ovarian Res; 2018 Sep; 11(1):77. PubMed ID: 30176911
[TBL] [Abstract][Full Text] [Related]
9. [Expression of ARID1A in ovarian seromucinous neoplasms and its clinicopathological significance].
Ding XH; Tian X; Wang LQ; Wang Y; Liu AJ
Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):588-593. PubMed ID: 32486536
[No Abstract] [Full Text] [Related]
10. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
[No Abstract] [Full Text] [Related]
11. PAX2, PAX8, and PR are correlated with ovarian seromucinous borderline tumor with endometriosis.
Yun BS; Won S; Kim JH; Lee N; Kim M; Kim MK; Kim ML; Jung YW; Kim JY; Seong SJ; Shin E
J Ovarian Res; 2022 Apr; 15(1):41. PubMed ID: 35387670
[TBL] [Abstract][Full Text] [Related]
12. [Clinical analysis of 23 cases with simultaneous double primary gynecological malignant tumors].
He Y; Wang Y; Ji C; Liu Y; Wu YM
Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):352-360. PubMed ID: 35658326
[No Abstract] [Full Text] [Related]
13. Clinicopathologic Features and the Loss of ARID1A Expression in Ovarian Seromucinous Borderline Tumors and Seromucinous Carcinomas.
Ok Atılgan A; Özen Ö; Haberal Reyhan AN; Ayhan A
Int J Surg Pathol; 2023 Jun; 31(4):398-408. PubMed ID: 36452965
[TBL] [Abstract][Full Text] [Related]
14. Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A.
Wu CH; Mao TL; Vang R; Ayhan A; Wang TL; Kurman RJ; Shih IeM
Int J Gynecol Pathol; 2012 Jul; 31(4):297-303. PubMed ID: 22653341
[TBL] [Abstract][Full Text] [Related]
15. Ovarian Mucinous Carcinoma with a Yolk sac Tumor-Like Component: A Report of Three Cases with a Literature Review for Prognostic Analysis.
Tsujimura M; Fujimoto M; Minamiguchi S; Miyamoto T; Ueda A; Hamanishi J; Mandai M; Haga H
Int J Surg Pathol; 2023 Aug; 31(5):765-771. PubMed ID: 36314449
[TBL] [Abstract][Full Text] [Related]
16. Ovarian mucinous and mixed epithelial carcinomas of mullerian (endocervical-like) type: a clinicopathologic analysis of four cases of an uncommon variant associated with endometriosis.
Lee KR; Nucci MR
Int J Gynecol Pathol; 2003 Jan; 22(1):42-51. PubMed ID: 12496697
[TBL] [Abstract][Full Text] [Related]
17. Intestinal-type mucinous ovarian carcinoma arising from a seromucinous precursor lesion.
Santoro A; D'Alessandris N; Travaglino A; Arciuolo D; Inzani F; Angelico G; Scaglione G; Valente M; Raffone A; Zannoni GF
Eur Rev Med Pharmacol Sci; 2022 Feb; 26(4):1263-1267. PubMed ID: 35253183
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of lymphadenectomy and prevalence of lymph node metastasis in clinically-apparent stage I endometrioid and mucinous ovarian carcinoma.
Nasioudis D; Chapman-Davis E; Witkin SS; Holcomb K
Gynecol Oncol; 2017 Feb; 144(2):414-419. PubMed ID: 27908528
[TBL] [Abstract][Full Text] [Related]
19. Prognostic similarity between ovarian mucinous carcinoma with expansile invasion and ovarian mucinous borderline tumor: A retrospective analysis.
Hada T; Miyamoto M; Ishibashi H; Matsuura H; Sakamoto T; Kakimoto S; Iwahashi H; Suzuki R; Sato K; Tsuda H; Takano M
Medicine (Baltimore); 2021 Aug; 100(32):e26895. PubMed ID: 34397915
[TBL] [Abstract][Full Text] [Related]
20. AGR2 expression in ovarian tumours: a potential biomarker for endometrioid and mucinous differentiation.
Armes JE; Davies CM; Wallace S; Taheri T; Perrin LC; Autelitano DJ
Pathology; 2013 Jan; 45(1):49-54. PubMed ID: 23222243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]